vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Logistic Properties of the Americas (LPA). Click either name above to swap in a different company.

Logistic Properties of the Americas is the larger business by last-quarter revenue ($50.1M vs $45.1M, roughly 1.1× Amarin Corp plc). Logistic Properties of the Americas runs the higher net margin — 32.1% vs -23.3%, a 55.4% gap on every dollar of revenue.

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Logistic Properties of the Americas is a specialized industrial real estate firm that acquires, develops and manages logistics properties across North, Central and South America. Its portfolio includes distribution centers, warehouses and last-mile delivery facilities, serving e-commerce, retail, manufacturing and third-party logistics clients.

AMRN vs LPA — Head-to-Head

Bigger by revenue
LPA
LPA
1.1× larger
LPA
$50.1M
$45.1M
AMRN
Higher net margin
LPA
LPA
55.4% more per $
LPA
32.1%
-23.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
LPA
LPA
Revenue
$45.1M
$50.1M
Net Profit
$-10.5M
$16.1M
Gross Margin
Operating Margin
35.5%
81.7%
Net Margin
-23.3%
32.1%
Revenue YoY
7.0%
Net Profit YoY
33.0%
EPS (diluted)
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
LPA
LPA
Q1 26
$45.1M
Q4 25
$49.2M
$50.1M
Q3 25
$49.7M
$32.7M
Q2 25
$72.7M
$21.5M
Q1 25
$42.0M
$10.5M
Q4 24
$62.3M
Q3 24
$42.3M
$19.2M
Q2 24
$67.5M
Net Profit
AMRN
AMRN
LPA
LPA
Q1 26
$-10.5M
Q4 25
$-1.2M
$16.1M
Q3 25
$-7.7M
Q2 25
$-14.1M
Q1 25
$-15.7M
Q4 24
$-48.6M
Q3 24
$-25.1M
Q2 24
$1.5M
Gross Margin
AMRN
AMRN
LPA
LPA
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
Q2 24
63.4%
Operating Margin
AMRN
AMRN
LPA
LPA
Q1 26
35.5%
Q4 25
-12.9%
81.7%
Q3 25
-22.4%
Q2 25
-22.0%
Q1 25
-39.9%
Q4 24
-84.3%
Q3 24
-59.5%
Q2 24
-0.8%
Net Margin
AMRN
AMRN
LPA
LPA
Q1 26
-23.3%
Q4 25
-2.5%
32.1%
Q3 25
-15.6%
Q2 25
-19.4%
Q1 25
-37.4%
Q4 24
-78.0%
Q3 24
-59.4%
Q2 24
2.3%
EPS (diluted)
AMRN
AMRN
LPA
LPA
Q1 26
Q4 25
$0.00
$0.33
Q3 25
$-0.02
$0.09
Q2 25
$-0.03
$-0.06
Q1 25
$-0.04
Q4 24
$-0.12
Q3 24
$-0.06
$-1.26
Q2 24
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
LPA
LPA
Cash + ST InvestmentsLiquidity on hand
$307.8M
$27.3M
Total DebtLower is stronger
$296.8M
Stockholders' EquityBook value
$324.6M
Total Assets
$645.8M
$700.8M
Debt / EquityLower = less leverage
0.91×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
LPA
LPA
Q1 26
$307.8M
Q4 25
$302.6M
$27.3M
Q3 25
$286.6M
Q2 25
$298.7M
Q1 25
$281.8M
Q4 24
$294.2M
Q3 24
$305.7M
Q2 24
$306.7M
Total Debt
AMRN
AMRN
LPA
LPA
Q1 26
Q4 25
$296.8M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
AMRN
AMRN
LPA
LPA
Q1 26
Q4 25
$459.3M
$324.6M
Q3 25
$458.9M
Q2 25
$464.9M
Q1 25
$473.7M
Q4 24
$486.2M
Q3 24
$531.4M
Q2 24
$551.9M
Total Assets
AMRN
AMRN
LPA
LPA
Q1 26
$645.8M
Q4 25
$670.8M
$700.8M
Q3 25
$659.8M
Q2 25
$670.1M
Q1 25
$655.7M
Q4 24
$685.3M
Q3 24
$750.6M
Q2 24
$799.9M
Debt / Equity
AMRN
AMRN
LPA
LPA
Q1 26
Q4 25
0.91×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
LPA
LPA
Operating Cash FlowLast quarter
$21.6M
Free Cash FlowOCF − Capex
$21.4M
FCF MarginFCF / Revenue
42.7%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$12.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
LPA
LPA
Q1 26
Q4 25
$15.3M
$21.6M
Q3 25
$-12.7M
$14.4M
Q2 25
$16.6M
$7.2M
Q1 25
$-12.5M
$4.4M
Q4 24
$-13.3M
Q3 24
$-2.4M
$8.3M
Q2 24
$-2.7M
Free Cash Flow
AMRN
AMRN
LPA
LPA
Q1 26
Q4 25
$21.4M
Q3 25
$-7.3M
Q2 25
$-3.1M
Q1 25
$966.4K
Q4 24
Q3 24
$-2.4M
Q2 24
FCF Margin
AMRN
AMRN
LPA
LPA
Q1 26
Q4 25
42.7%
Q3 25
-22.2%
Q2 25
-14.4%
Q1 25
9.2%
Q4 24
Q3 24
-12.3%
Q2 24
Capex Intensity
AMRN
AMRN
LPA
LPA
Q1 26
Q4 25
0.3%
Q3 25
66.1%
Q2 25
47.9%
Q1 25
32.5%
Q4 24
Q3 24
55.5%
Q2 24
Cash Conversion
AMRN
AMRN
LPA
LPA
Q1 26
Q4 25
1.34×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

LPA
LPA

Segment breakdown not available.

Related Comparisons